Singapore, Singapore · Founded 2007 · Privately Held (backing)
Developer of a robotic prostate biopsy and treatment system designed for improved clinical outcomes. Biobot Surgical is based in Singapore, Singapore and was founded in 2007. Its last reported valuation was $54.3 million in Mar 2024. It has raised $38.7 million.
Last reported valuation
$54.3M
Oct 2026
Priced at
—
Total raised
$38.7M
Last round
—
Team — not yet on record
No current team members for Biobot Surgical are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biobot Surgical with a free account
·The complete investor list: 16 names
·Watch Biobot Surgical: the Monday email on marks, rounds and moves
